Vale SA
VALE
Petroleo Brasileiro SA Petrobras
PBR
Apple
AAPL
4
Ecopetrol
EC
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
ATHA Athira
- 0.307
- +0.006+1.93%
Trading Mar 28 12:02 ET
11.98MMarket Cap-0.12P/E (TTM)
0.320High0.300Low47.84KVolume0.301Open0.301Pre Close14.72KTurnover0.17%Turnover RatioLossP/E (Static)39.04MShares3.67052wk High0.27P/B8.46MFloat Cap0.30052wk Low--Dividend TTM27.56MShs Float34.790Historical High--Div YieldTTM6.58%Amplitude0.300Historical Low0.307Avg Price1Lot Size
About Athira Company
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Company Profile
SymbolATHA
Company NameAthira
Listing DateSep 18, 2020
Issue Price17.00
Founded2011
CEODr. Mark J. Litton, PhD
MarketNASDAQ
Employees26
Fiscal Year Ends12-31
Address18706 North Creek Parkway,Suite 104
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-620-8501
Websitehttp://www.athira.com
Company Executives
- Name
- Position
- Salary
- Dr. Mark J. Litton, PhD
- Director, President and Chief Executive Officer
- 2.26M
- Dr. Kevin Church, PhD
- Chief Scientific Officer
- --
- Robert Renninger
- Principal Financial Officer, Principal Accounting Officer and Vice President, Finance
- --
- Barbara Kosacz, J.D.
- Independent Director
- 102.39K
- Joseph Edelman
- Independent Director
- 92.77K
- John M. Fluke, Jr
- Independent Director
- 95.89K
- James A. Johnson
- Independent Director
- 106.87K
- Grant E. Pickering
- Independent Director
- 96.53K
- Dr. Michael A. Panzara, M.D.
- Independent Director
- 89.36K
- Mark Worthington
- General Counsel and Corporate Secretary
- --
- Kelly A. Romano
- Chairwoman of the Board
- 124.68K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings